Tom Manley

1.1k total citations · 1 hit paper
6 papers, 509 citations indexed

About

Tom Manley is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Nephrology. According to data from OpenAlex, Tom Manley has authored 6 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Endocrinology, Diabetes and Metabolism, 2 papers in Surgery and 2 papers in Nephrology. Recurrent topics in Tom Manley's work include Diabetes Treatment and Management (3 papers), Pancreatic function and diabetes (2 papers) and Diabetes Management and Research (2 papers). Tom Manley is often cited by papers focused on Diabetes Treatment and Management (3 papers), Pancreatic function and diabetes (2 papers) and Diabetes Management and Research (2 papers). Tom Manley collaborates with scholars based in United States, Australia and Netherlands. Tom Manley's co-authors include Hiddo J.L. Heerspink, Vlado Perkovic, Kerry Willis, Shoshana H. Ballew, Ron T. Gansevoort, Yingying Sang, Edward F. Vonesh, Adeera Levin, Josef Coresh and Kai‐Uwe Eckardt and has published in prestigious journals such as Diabetes, Human Reproduction and American Journal of Kidney Diseases.

In The Last Decade

Tom Manley

6 papers receiving 500 citations

Hit Papers

Change in Albuminuria and GFR as End Points for Clinical ... 2019 2026 2021 2023 2019 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency
    2019 314 citations Andrew S. Levey, Ron T. Gansevoort et al. American Journal of Kidney Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Manley United States 5 269 235 113 84 77 6 509
Clara García-Carro Spain 12 157 0.6× 148 0.6× 115 1.0× 90 1.1× 49 0.6× 28 499
Shinichi Antoku Japan 13 203 0.8× 168 0.7× 97 0.9× 93 1.1× 92 1.2× 33 442
Michiko Togane Japan 13 216 0.8× 197 0.8× 102 0.9× 94 1.1× 104 1.4× 31 464
Christopher C. Kaltenecker Austria 13 180 0.7× 147 0.6× 227 2.0× 99 1.2× 160 2.1× 21 643
Jennifer A. Schaub United States 12 100 0.4× 155 0.7× 100 0.9× 107 1.3× 78 1.0× 25 537
Yume Nagaoka Japan 13 248 0.9× 283 1.2× 65 0.6× 51 0.6× 87 1.1× 39 569
Eirini Lioudaki United Kingdom 12 138 0.5× 85 0.4× 96 0.8× 57 0.7× 83 1.1× 31 362
P. Ruggenenti Italy 7 166 0.6× 280 1.2× 72 0.6× 56 0.7× 144 1.9× 12 487
Antonio Pacilli Italy 11 363 1.3× 331 1.4× 125 1.1× 104 1.2× 86 1.1× 16 656
Vittorio Ortalda Italy 9 158 0.6× 380 1.6× 75 0.7× 99 1.2× 70 0.9× 16 588

Countries citing papers authored by Tom Manley

Since Specialization
Citations

This map shows the geographic impact of Tom Manley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Manley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Manley more than expected).

Fields of papers citing papers by Tom Manley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Manley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Manley. The network helps show where Tom Manley may publish in the future.

Co-authorship network of co-authors of Tom Manley

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Manley. A scholar is included among the top collaborators of Tom Manley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Manley. Tom Manley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
2.
Gook, Debra A., et al.. (2021). Experience with transplantation of human cryopreserved ovarian tissue to a sub-peritoneal abdominal site. Human Reproduction. 36(9). 2473–2483. 10 indexed citations
3.
Neumiller, Joshua J., Jay H. Shubrook, Tom Manley, Radica Z. Alicic, & Katherine R. Tuttle. (2021). Optimizing use of SGLT2 inhibitors and other evidence-based therapies to improve outcomes in patients with type 2 diabetes and chronic kidney disease: An opportunity for pharmacists. American Journal of Health-System Pharmacy. 79(1). e65–e70. 7 indexed citations
4.
Tuttle, Katherine R., Frank C. Brosius, Matthew A. Cavender, et al.. (2020). SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. American Journal of Kidney Diseases. 77(1). 94–109. 93 indexed citations
5.
Tuttle, Katherine R., Frank C. Brosius, Matthew A. Cavender, et al.. (2020). SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. Diabetes. 70(1). 1–16. 81 indexed citations
6.
Levey, Andrew S., Ron T. Gansevoort, Josef Coresh, et al.. (2019). Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency. American Journal of Kidney Diseases. 75(1). 84–104. 314 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clara García-Carro Breakdown of academic impact, for papers by Shinichi Antoku Breakdown of academic impact, for papers by Michiko Togane Breakdown of academic impact, for papers by Christopher C. Kaltenecker Breakdown of academic impact, for papers by Jennifer A. Schaub Breakdown of academic impact, for papers by Yume Nagaoka Breakdown of academic impact, for papers by Eirini Lioudaki Breakdown of academic impact, for papers by P. Ruggenenti Breakdown of academic impact, for papers by Antonio Pacilli Breakdown of academic impact, for papers by Vittorio Ortalda
Rankless by CCL
2026